Summit Therapeutics: World Lung Data Not Enough For Ivonescimab To Unseat Keytruda (Yet)
Michal Krakowiak/E+ via Getty Images Topline Summary and Update When I last wrote about Summit Therapeutics (NASDAQ:SMMT) back around the...
Michal Krakowiak/E+ via Getty Images Topline Summary and Update When I last wrote about Summit Therapeutics (NASDAQ:SMMT) back around the...
By Johann M Cherian and Purvi Agarwal (Reuters) - Wall Street's main indexes were lower on Tuesday, weighed down by...
Texas Gov. Greg Abbott, a Republican, issued an executive order mandating that public hospitals in the state gather data on...
cemagraphics When it comes to the payroll reports at the start of each month, ADP reported last Wednesday that only...
The jumped on Friday, marking its best session of the year, as investors closed a strong month after the Federal...
Yanawut Telephone and Data Systems, Inc. DEP SR UU PE PFD (NYSE:TDS.PR.U) remains an interesting way to play the company's...
By Laila Kearney NEW YORK (Reuters) - Talen Energy has asked U.S. regulators to reject a challenge to its recent...
Jonathan Knowles Annovis Bio's Parkinson's Trial Announcement On Tuesday, July 2, Annovis Bio, Inc. (NYSE:ANVS) announced data from their long-expected...
Nikada By Lynn Song Weak confidence continued to drag growth China saw a mixed bag in terms of data releases...
SHANGHAI (Reuters) - Tesla (NASDAQ:) has cut output of its best-selling Model Y electric car by a double-digit percentage number...